• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

September 19, 2018

Trending News Today: Bipartisan Group Proposes Lifting Medicaid Restrictions on Substance Abuse Treatment

Author(s):

SPT Staff

Top news of the day from across the health care landscape

A bipartisan group of senators want Congress’ final opioids package to lift a restriction on Medicaid funding for substance abuse treatment, The Hill reported. According to the article, a proposal introduced on Tuesday would allow states to use Medicaid money to pay for coverage at addiction treatment facilities for individuals diagnosed with substance use disorders for up to 90 consecutive days. Supporters say it would expand access to treatment for substance abuse but opponents worry about the cost, the article reported. Current federal law bans the use of Medicaid funding for inpatient residential treatment facilities with more than 16 beds.

Close relatives of patients with cancer may be more willing to receive testing for genetic mutations if it was accessible and affordable, Reuters reported. According to the article, researchers asked 741 individuals with 1 of 30 cancer-associated mutations and 360 of their close relatives to invite other close relatives to get their genes sequenced at a low cost. Over the first year of the discount testing program, 48% of invited relatives agreed to testing. Approximately 48% of these close relatives tested positive for the same genetic mutation linked to cancer in their family member, and about 5% had a different variant also associated with tumors, the study found. Twelve percent of these relatives who tested positive then invited additional family members to get tests, the article reported. According to the authors, only about one-third of relatives typically get tested.

A new study found that less than 1 in 5 teens with chronic health problems have made plans with their pediatricians to take charge of their own care and transition to physicians who treat adults, Reuters reported. According to the article, the researchers examined data from surveys of parents and caregivers of approximately 21,000 children aged 12 to 17 years, including 5900 who were being treated for ongoing medical issues. Overall, just 17% of teens with special health needs and 14% without any medical issues appeared prepared to transition to adult care, the article reported.

Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Microscopic View of Hematological Slide Showing Thrombocytopenia and Low Platelet Count in Blood
May 31st 2025

IVIG Increases Platelet Counts in Pregnant Patients With Severe Thrombocytopenia, With Identifiable Aspects of Response

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Image depicting kidney affected by CKD -- Image credit: Crystal light | stock.adobe.com
May 30th 2025

Cellular Senescence is a Central Driver of Chronic Kidney Disease-Related Kidney Fibrosis

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Model of a kidney depicting CKD -- Image credit: kanruthai | stock.adobe.com
May 29th 2025

Childhood Cancer Survivors at an Increased Risk of Developing CKD, Study Finds

Gillian McGovern, Associate Editor
Prague, Czech Republic - August 28 2024: STELARA box with USTEKINUMAB active substance by JANSSEN, used for psoriasis, Crohn’s disease, and ulcerative colitis.
May 28th 2025

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

Luke Halpern, Assistant Editor
Related Content
Advertisement
Microscopic View of Hematological Slide Showing Thrombocytopenia and Low Platelet Count in Blood
May 31st 2025

IVIG Increases Platelet Counts in Pregnant Patients With Severe Thrombocytopenia, With Identifiable Aspects of Response

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Image depicting kidney affected by CKD -- Image credit: Crystal light | stock.adobe.com
May 30th 2025

Cellular Senescence is a Central Driver of Chronic Kidney Disease-Related Kidney Fibrosis

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Model of a kidney depicting CKD -- Image credit: kanruthai | stock.adobe.com
May 29th 2025

Childhood Cancer Survivors at an Increased Risk of Developing CKD, Study Finds

Gillian McGovern, Associate Editor
Prague, Czech Republic - August 28 2024: STELARA box with USTEKINUMAB active substance by JANSSEN, used for psoriasis, Crohn’s disease, and ulcerative colitis.
May 28th 2025

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.